26 patients with poor risk acute myelogenous leukemia ( elderly , in relapse or resistant ) were treated with a combination of oral idarubicin ( 30 mg/m2/d for 3 days ) and low dose subcutaneous cytarabine ( 10 mg/m2 twice a day for 10 days ) .
C0023467
acute myelogenous leukemia
C0020789
idarubicin